Document is current
Any future updates will be listed below
-
Authors
Komic, Hana https://orcid.org/0000-0001-5209-393X
Schmachtel, Tessa
Simoes, Catia
Külp, Marius https://orcid.org/0000-0002-6594-8412
Yu, Weijia https://orcid.org/0000-0001-8471-3048
Jolly, Adrien https://orcid.org/0000-0002-2609-5621
Nilsson, Malin S. https://orcid.org/0000-0002-0981-2617
Gonzalez, Carmen https://orcid.org/0009-0001-3074-9229
Prosper, Felipe https://orcid.org/0000-0001-6115-8790
Bonig, Halvard
Paiva, Bruno https://orcid.org/0000-0003-1977-3815
Thorén, Fredrik B. https://orcid.org/0000-0003-2167-7451
Rieger, Michael A. https://orcid.org/0000-0002-4158-5872
-
Funding
Funding for this research was provided by:
José Carreras Leukämie-Stiftung (DJCLS 15R/2023)
Deutsche Forschungsgemeinschaft (RI 2462/9-1, RI 2462/10-1)
Hessisches Ministerium für Wissenschaft und Kunst (III L 5 − 519/03/03.001 – [0015])
- License Information
-
More Information
Article History
Received: 3 May 2024
Accepted: 11 February 2025
First Online: 7 March 2025
Competing interests
: The authors received research funding in the form of free reagents from BD Biosciences within the BD Multiomics Alliance. H.B. has received licensing fees and royalties from Medac, research support from Erydel, Miltenyi, Sandoz-Hexal (a Novartis company), honoraria or speaker fees from Medac, Miltenyi, Novartis and Terumo BCT, consultancy or membership in advisory boards for Apriligen, Arensia, Boehringer-Ingelheim Vetmed, Celgene (a BMS company), Editas, Medac, NMDP, Novartis, Provirex and Sandoz-Hexal, and acknowledges stock ownership in Healthineers, none of which are of relevance to the work at hand. B.P. reports honoraria for lectures from and membership on advisory boards with Adaptive, Amgen, Becton Dickinson, Bristol-Myers Squibb-Celgene, Janssen, Merck, Novartis, Roche, Sanofi and Takeda; unrestricted grants from Bristol-Myers Squibb-Celgene, EngMab, Roche, Sanofi, and Takeda; and consultancy for Bristol-Myers Squibb-Celgene, Janssen, Sanofi, and Takeda, none of which are of relevance to the work at hand. The remaining authors declare no competing interests.
